Skip to content

Lignocaine jelly facilitating Fiberoptic intubation

Topicalisation of airway for awake fiberoptic nasotracheal intubation : A comparison of two different methods.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033161
Enrollment
60
Registered
2021-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Nebulization with 4% lidocaine for awake fiberoptic intubation: Nebulisation with 4%lidocaine (5ml) with transtracheal block with 2ml of 4% lidocaine for topicalisation Control Interven

Sponsors

Rajiv Gandhi Cancer Institute and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with neoplasm of lip, oral cavity or pharynx requiring awake fiberoptic intubation due to restricted mouth opening or restricted neck movements ASA grade 1-3

Exclusion criteria

Exclusion criteria: Patient refusal Allergy to local anaesthetic agents History of seizure disorder ASA grade 4 and 5

Design outcomes

Primary

MeasureTime frame
To assess the quality of airway anaesthesia To compare the intubation times of the two techniquesTimepoint: T1 baseline T2 20 mins after anaesthetising techniques

Secondary

MeasureTime frame
1.Intubating condition of the vocal cords 2.Patient comfort score 3.Serum lidocaine levelsTimepoint: 1.At the time of fiberoptic intubation 2.From the time of insertion of endotracheal tube in the nostril till successful passage into the trachea 3.30 minutes after lidocaine instillation

Countries

India

Contacts

Public ContactDr Mamta Dubey

Rajiv Gandhi Cancer Institute and Research Centre , Sector 5, Rohini

ek_mamta@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026